 Tudor Moldoveanu
Concepts (209)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| bcl-2 Homologous Antagonist-Killer Protein | 11 | 2025 | 21 | 4.910 |
Why?
| | Apoptosis | 23 | 2025 | 1121 | 4.450 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 13 | 2022 | 128 | 3.510 |
Why?
| | Mitochondria | 8 | 2024 | 425 | 2.140 |
Why?
| | Mitochondrial Membranes | 8 | 2021 | 22 | 1.820 |
Why?
| | bcl-2-Associated X Protein | 9 | 2025 | 58 | 1.740 |
Why?
| | Protein Kinases | 4 | 2019 | 74 | 1.420 |
Why?
| | BH3 Interacting Domain Death Agonist Protein | 8 | 2023 | 14 | 1.280 |
Why?
| | Calpain | 9 | 2010 | 26 | 1.170 |
Why?
| | Inositol Phosphates | 2 | 2019 | 14 | 0.780 |
Why?
| | Membrane Proteins | 2 | 2022 | 337 | 0.700 |
Why?
| | MAP Kinase Kinase Kinases | 1 | 2019 | 19 | 0.650 |
Why?
| | Models, Molecular | 10 | 2025 | 352 | 0.620 |
Why?
| | Cell Membrane Permeability | 2 | 2018 | 24 | 0.610 |
Why?
| | Animals | 25 | 2024 | 13507 | 0.590 |
Why?
| | Protein Conformation | 8 | 2020 | 179 | 0.580 |
Why?
| | Necrosis | 1 | 2018 | 171 | 0.570 |
Why?
| | Protein Binding | 7 | 2025 | 673 | 0.520 |
Why?
| | Crystallography, X-Ray | 7 | 2022 | 156 | 0.480 |
Why?
| | Binding Sites | 8 | 2020 | 377 | 0.480 |
Why?
| | Permeability | 6 | 2019 | 67 | 0.460 |
Why?
| | Humans | 28 | 2025 | 52593 | 0.400 |
Why?
| | Phosphorylation | 5 | 2019 | 530 | 0.360 |
Why?
| | Liposomes | 3 | 2022 | 53 | 0.350 |
Why?
| | Protein Multimerization | 5 | 2016 | 57 | 0.340 |
Why?
| | Ligands | 3 | 2022 | 207 | 0.340 |
Why?
| | Amino Acid Sequence | 12 | 2020 | 574 | 0.330 |
Why?
| | Enzyme Activation | 4 | 2019 | 269 | 0.320 |
Why?
| | Magnetic Resonance Spectroscopy | 4 | 2018 | 253 | 0.310 |
Why?
| | Signal Transduction | 8 | 2020 | 1714 | 0.310 |
Why?
| | Protein Structure, Tertiary | 6 | 2016 | 252 | 0.310 |
Why?
| | Calcium | 4 | 2008 | 374 | 0.310 |
Why?
| | Catalytic Domain | 1 | 2008 | 61 | 0.300 |
Why?
| | Calcium-Binding Proteins | 1 | 2008 | 58 | 0.300 |
Why?
| | Protein Structure, Secondary | 5 | 2018 | 71 | 0.300 |
Why?
| | Mice | 12 | 2024 | 5958 | 0.280 |
Why?
| | Zinc Compounds | 1 | 2006 | 1 | 0.270 |
Why?
| | Chlorides | 1 | 2006 | 43 | 0.260 |
Why?
| | Cell Death | 3 | 2022 | 175 | 0.260 |
Why?
| | Kinetics | 4 | 2020 | 622 | 0.260 |
Why?
| | Molecular Sequence Data | 9 | 2010 | 773 | 0.250 |
Why?
| | Protein Processing, Post-Translational | 2 | 2020 | 153 | 0.220 |
Why?
| | Cytochromes c | 3 | 2020 | 28 | 0.220 |
Why?
| | bcl-X Protein | 5 | 2017 | 54 | 0.210 |
Why?
| | Fatty Acids | 1 | 2024 | 151 | 0.210 |
Why?
| | Dimerization | 3 | 2020 | 51 | 0.200 |
Why?
| | HT29 Cells | 2 | 2019 | 14 | 0.190 |
Why?
| | Proto-Oncogene Proteins | 4 | 2017 | 151 | 0.190 |
Why?
| | Cell Survival | 3 | 2019 | 602 | 0.190 |
Why?
| | Calcium Signaling | 1 | 2002 | 52 | 0.190 |
Why?
| | Lipids | 1 | 2022 | 160 | 0.180 |
Why?
| | Gene Expression Regulation, Neoplastic | 4 | 2018 | 857 | 0.170 |
Why?
| | Cytochromes | 1 | 2020 | 3 | 0.170 |
Why?
| | Cytosol | 1 | 2020 | 81 | 0.160 |
Why?
| | Receptor-Interacting Protein Serine-Threonine Kinases | 2 | 2018 | 5 | 0.160 |
Why?
| | Sequence Alignment | 5 | 2011 | 121 | 0.160 |
Why?
| | Sf9 Cells | 1 | 2019 | 2 | 0.160 |
Why?
| | Spodoptera | 1 | 2019 | 5 | 0.160 |
Why?
| | Peptide Fragments | 6 | 2017 | 210 | 0.160 |
Why?
| | Molecular Conformation | 1 | 2019 | 69 | 0.150 |
Why?
| | Cell Line | 2 | 2019 | 1033 | 0.150 |
Why?
| | Alzheimer Disease | 1 | 2022 | 331 | 0.150 |
Why?
| | Structural Homology, Protein | 1 | 2018 | 9 | 0.150 |
Why?
| | Ion Channel Gating | 1 | 2018 | 33 | 0.150 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 1 | 2018 | 35 | 0.150 |
Why?
| | Histones | 1 | 2020 | 316 | 0.150 |
Why?
| | Protein Stability | 1 | 2018 | 46 | 0.140 |
Why?
| | Mutagenesis | 1 | 2018 | 60 | 0.140 |
Why?
| | Carrier Proteins | 1 | 2020 | 320 | 0.140 |
Why?
| | Androgen Receptor Antagonists | 1 | 2017 | 1 | 0.140 |
Why?
| | Glycine | 1 | 2018 | 75 | 0.140 |
Why?
| | Receptors, Androgen | 1 | 2017 | 47 | 0.140 |
Why?
| | Fibroblasts | 2 | 2016 | 359 | 0.130 |
Why?
| | Tumor Suppressor Proteins | 1 | 2017 | 128 | 0.130 |
Why?
| | Colonic Neoplasms | 1 | 2018 | 163 | 0.130 |
Why?
| | Repressor Proteins | 1 | 2017 | 154 | 0.130 |
Why?
| | Endoplasmic Reticulum-Associated Degradation | 1 | 2016 | 1 | 0.130 |
Why?
| | Mutation | 3 | 2018 | 1344 | 0.130 |
Why?
| | Transcription, Genetic | 1 | 2017 | 380 | 0.130 |
Why?
| | Phosphatidylinositol Phosphates | 1 | 2016 | 17 | 0.120 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2015 | 21 | 0.120 |
Why?
| | Rats | 4 | 2008 | 3203 | 0.120 |
Why?
| | Apoptosis Regulatory Proteins | 3 | 2011 | 87 | 0.120 |
Why?
| | Recombinant Proteins | 3 | 2006 | 496 | 0.120 |
Why?
| | Models, Biological | 2 | 2015 | 741 | 0.110 |
Why?
| | Coenzyme A | 1 | 2013 | 9 | 0.110 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2013 | 16 | 0.110 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2015 | 224 | 0.110 |
Why?
| | Xenopus laevis | 1 | 2013 | 44 | 0.110 |
Why?
| | Hydrolysis | 2 | 2003 | 68 | 0.100 |
Why?
| | Mutant Proteins | 1 | 2013 | 37 | 0.100 |
Why?
| | Oocytes | 1 | 2013 | 96 | 0.100 |
Why?
| | Mice, Inbred C57BL | 1 | 2018 | 1900 | 0.100 |
Why?
| | Mitochondria, Liver | 1 | 2011 | 69 | 0.090 |
Why?
| | Substrate Specificity | 2 | 2008 | 196 | 0.090 |
Why?
| | Recombinant Fusion Proteins | 1 | 2011 | 175 | 0.090 |
Why?
| | Receptors, Interleukin-4 | 1 | 2010 | 4 | 0.090 |
Why?
| | Alternative Splicing | 2 | 2017 | 61 | 0.090 |
Why?
| | Interleukin-4 | 1 | 2010 | 44 | 0.090 |
Why?
| | Selection, Genetic | 1 | 2010 | 27 | 0.080 |
Why?
| | Evolution, Molecular | 1 | 2010 | 95 | 0.080 |
Why?
| | EF Hand Motifs | 1 | 2008 | 1 | 0.080 |
Why?
| | Biocatalysis | 1 | 2008 | 15 | 0.080 |
Why?
| | Mice, Knockout | 3 | 2017 | 910 | 0.080 |
Why?
| | Sequence Homology, Amino Acid | 2 | 2010 | 137 | 0.070 |
Why?
| | Phenotype | 2 | 2017 | 800 | 0.070 |
Why?
| | Proto-Oncogene Proteins c-cbl | 1 | 2007 | 3 | 0.070 |
Why?
| | Structure-Activity Relationship | 1 | 2008 | 405 | 0.070 |
Why?
| | Neoplasms | 1 | 2017 | 1308 | 0.070 |
Why?
| | Ubiquitin | 1 | 2007 | 68 | 0.070 |
Why?
| | Combinatorial Chemistry Techniques | 1 | 2007 | 9 | 0.070 |
Why?
| | Cysteine Proteinase Inhibitors | 1 | 2007 | 21 | 0.070 |
Why?
| | KB Cells | 1 | 2006 | 3 | 0.070 |
Why?
| | Gene Expression Regulation | 1 | 2011 | 1006 | 0.070 |
Why?
| | Epoxy Compounds | 1 | 2007 | 47 | 0.060 |
Why?
| | Glycoproteins | 1 | 2007 | 122 | 0.060 |
Why?
| | Micelles | 1 | 2006 | 8 | 0.060 |
Why?
| | Peptide Library | 1 | 2005 | 16 | 0.060 |
Why?
| | Phospholipids | 1 | 2006 | 58 | 0.060 |
Why?
| | Peptides | 1 | 2005 | 236 | 0.060 |
Why?
| | Sensitivity and Specificity | 1 | 2006 | 883 | 0.060 |
Why?
| | Coenzyme A Ligases | 1 | 2024 | 6 | 0.060 |
Why?
| | Transposases | 1 | 2004 | 10 | 0.060 |
Why?
| | Protein Precursors | 1 | 2004 | 42 | 0.050 |
Why?
| | Transfection | 2 | 2017 | 369 | 0.050 |
Why?
| | Calorimetry, Differential Scanning | 1 | 2003 | 8 | 0.050 |
Why?
| | Calcium Chloride | 1 | 2003 | 2 | 0.050 |
Why?
| | HEK293 Cells | 2 | 2017 | 232 | 0.050 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2003 | 96 | 0.050 |
Why?
| | Protein Folding | 1 | 2003 | 61 | 0.050 |
Why?
| | Leucine | 1 | 2004 | 114 | 0.050 |
Why?
| | Restriction Mapping | 1 | 2003 | 33 | 0.050 |
Why?
| | Cell Proliferation | 2 | 2017 | 1029 | 0.050 |
Why?
| | Molecular Mimicry | 2 | 2017 | 36 | 0.050 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2003 | 97 | 0.050 |
Why?
| | Tryptophan | 1 | 2003 | 89 | 0.050 |
Why?
| | Proteins | 1 | 2006 | 354 | 0.050 |
Why?
| | Ribonucleoprotein, U1 Small Nuclear | 1 | 2022 | 1 | 0.050 |
Why?
| | Oxidation-Reduction | 1 | 2024 | 328 | 0.050 |
Why?
| | Temperature | 1 | 2003 | 165 | 0.050 |
Why?
| | Cell Membrane | 2 | 2016 | 242 | 0.050 |
Why?
| | Endoplasmic Reticulum | 2 | 2016 | 113 | 0.050 |
Why?
| | RNA Splicing | 1 | 2022 | 41 | 0.050 |
Why?
| | Protein Isoforms | 1 | 2002 | 125 | 0.050 |
Why?
| | Mammals | 2 | 2011 | 60 | 0.040 |
Why?
| | Proteome | 1 | 2022 | 170 | 0.040 |
Why?
| | Sequence Homology | 1 | 2020 | 16 | 0.040 |
Why?
| | Amino Acid Motifs | 1 | 2020 | 59 | 0.040 |
Why?
| | Molecular Dynamics Simulation | 1 | 2020 | 44 | 0.040 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2003 | 1378 | 0.040 |
Why?
| | Jurkat Cells | 1 | 2018 | 28 | 0.040 |
Why?
| | Herpesvirus 1, Human | 1 | 2018 | 17 | 0.040 |
Why?
| | Phosphotransferases (Alcohol Group Acceptor) | 1 | 2018 | 22 | 0.040 |
Why?
| | Anilides | 1 | 2017 | 19 | 0.030 |
Why?
| | NIH 3T3 Cells | 1 | 2017 | 52 | 0.030 |
Why?
| | Mice, Inbred NOD | 1 | 2017 | 92 | 0.030 |
Why?
| | Mice, SCID | 1 | 2017 | 182 | 0.030 |
Why?
| | Mice, Nude | 1 | 2017 | 235 | 0.030 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2018 | 181 | 0.030 |
Why?
| | RNA Interference | 1 | 2017 | 186 | 0.030 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2017 | 222 | 0.030 |
Why?
| | Molecular Structure | 1 | 2017 | 315 | 0.030 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2018 | 396 | 0.030 |
Why?
| | Embryo, Mammalian | 1 | 2016 | 71 | 0.030 |
Why?
| | Genotype | 1 | 2017 | 571 | 0.030 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2016 | 140 | 0.030 |
Why?
| | Indoles | 1 | 2017 | 277 | 0.030 |
Why?
| | Caspase 2 | 1 | 2013 | 1 | 0.030 |
Why?
| | Cell Line, Tumor | 1 | 2017 | 1436 | 0.030 |
Why?
| | Transcriptional Activation | 1 | 2013 | 128 | 0.030 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2013 | 147 | 0.030 |
Why?
| | Gene Expression Profiling | 1 | 2017 | 1110 | 0.020 |
Why?
| | Molecular Sequence Annotation | 1 | 2011 | 28 | 0.020 |
Why?
| | Time Factors | 1 | 2017 | 3000 | 0.020 |
Why?
| | HeLa Cells | 1 | 2011 | 261 | 0.020 |
Why?
| | Protein Structure, Quaternary | 1 | 2010 | 26 | 0.020 |
Why?
| | Likelihood Functions | 1 | 2010 | 56 | 0.020 |
Why?
| | Calorimetry | 1 | 2010 | 6 | 0.020 |
Why?
| | Species Specificity | 1 | 2010 | 191 | 0.020 |
Why?
| | Multigene Family | 1 | 2010 | 50 | 0.020 |
Why?
| | Protein Interaction Mapping | 1 | 2010 | 38 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2010 | 310 | 0.020 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2010 | 201 | 0.020 |
Why?
| | Sequence Analysis, DNA | 1 | 2010 | 230 | 0.020 |
Why?
| | Phylogeny | 1 | 2010 | 234 | 0.020 |
Why?
| | Genetic Variation | 1 | 2010 | 230 | 0.020 |
Why?
| | Antineoplastic Agents | 1 | 2017 | 1221 | 0.020 |
Why?
| | Autophagy | 1 | 2010 | 199 | 0.020 |
Why?
| | Receptor Protein-Tyrosine Kinases | 1 | 2007 | 52 | 0.020 |
Why?
| | Cathepsins | 1 | 2007 | 6 | 0.020 |
Why?
| | Electron Spin Resonance Spectroscopy | 1 | 2006 | 10 | 0.020 |
Why?
| | Nuclear Magnetic Resonance, Biomolecular | 1 | 2006 | 33 | 0.020 |
Why?
| | Consensus Sequence | 1 | 2005 | 22 | 0.020 |
Why?
| | Biotinylation | 1 | 2005 | 28 | 0.020 |
Why?
| | Chromatography, Gel | 1 | 2005 | 39 | 0.020 |
Why?
| | Fluorescence Resonance Energy Transfer | 1 | 2005 | 17 | 0.020 |
Why?
| | Acetylation | 1 | 2005 | 96 | 0.020 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2005 | 66 | 0.020 |
Why?
| | Computer Simulation | 1 | 2006 | 290 | 0.010 |
Why?
| | Nitrilotriacetic Acid | 1 | 2004 | 1 | 0.010 |
Why?
| | Leupeptins | 1 | 2004 | 6 | 0.010 |
Why?
| | Edetic Acid | 1 | 2004 | 14 | 0.010 |
Why?
| | Nickel | 1 | 2004 | 11 | 0.010 |
Why?
| | Chelating Agents | 1 | 2004 | 31 | 0.010 |
Why?
| | Magnesium | 1 | 2004 | 32 | 0.010 |
Why?
| | Sequence Deletion | 1 | 2004 | 72 | 0.010 |
Why?
| | Protease Inhibitors | 1 | 2004 | 59 | 0.010 |
Why?
| | Male | 1 | 2017 | 26863 | 0.010 |
Why?
| | Female | 1 | 2017 | 28262 | 0.010 |
Why?
|
|
Moldoveanu's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|